European Leukemia Trial Registry
Trial: ETAL-4

More Details
Title Phase III Studie zu Panobinostat nach Stammzelltransplantation bei Hochrisiko-AMLund -MDS
Short Title ETAL-4
Trialgroup SAL
Type of Trial multicentric, randomized, prospective, open-label, double-group
Disease Myelodysplastic Syndrome(MDS) All subtypes
Acute myeloid leukemia(AML) AML all subtypes without FAB M3
Age 18 - 70 Jahre
Status Active
Start of Recruitment 11.12.2018
Leader Bug, PD Dr. med., Gesine

Study Physician
Bug, PD Dr. med., Gesine
Tel: +49 (0)69 6301 7369
Fax: +49 (0)69 6301 7463

Study assistance
Wagner-Schernick, Sandra
Tel: +49 (0)69 630183209

Study assistance General Contact Person
Taubenroth, Maja

Study Physician
Lang, Fabian

Shortprotocol Shortprotocol
created 22.10.2018 Student Studienregister
changed 17.04.2019 Zenawit Krüger
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | |